Freeman Kevin D

Galectin Therapeutics Inc. · Director

Freeman Kevin D is listed in public filings as director. This Freeman Kevin D insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Galectin Therapeutics Inc. (GALT). Investors use Freeman Kevin D's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Galectin Therapeutics Inc.GALT$20k5.5k sharesBuyDec 23, 2025$3.55--